Compare AstraZeneca plc (AZN) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs SAP SE — how do they compare? AstraZeneca plc trades at $157.96 (market cap $248.14B), while SAP SE trades at $206.82 (market cap $240.81B). The key difference: AstraZeneca plc and SAP SE are close in size by market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | SAP | |
|---|---|---|
Market Cap | $248.14B | $240.81B |
Sector | Health | Technology |
52-Week High | $209.48 | $280.46 |
52-Week Low | $147.06 | $146.38 |
Enterprise Value | $275.41B | $239.52B |
Dividend Yield | 2.01% | 1.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
